Furthermore, IGF-1 causes an increase in 1,25-dihydroxyvitamin D [1,25(OH)2D] levels by stimulating the expression and activity of the 1a-hydroxylase in the kidney, which leads to an altered calcium–phosphate balance in uncontrolled acromegaly (4, 8). Here, IGF1 is linked to acromegaly.